Shanti B Rywkin

Title: The Innovative Contributions of Shanti B. Rywkin

Introduction

Shanti B. Rywkin, an accomplished inventor based in Brooklyn, NY, has made significant strides in the field of medical technology and blood preservation. With six patents to her name, she has dedicated her career to improving the safety and efficacy of blood products through innovative processes.

Latest Patents

Among her latest patents, one notable invention is a method involving Vitamin E and its derivatives, which prevent potassium ion leakage and other types of damage in red blood cells that are virus sterilized by phthalocyanines and light. This process includes the addition of Vitamin E or a derivative during the irradiation of cell-containing compositions. The result is a protective effect on the cells, reducing the leakage of potassium and enhancing the longevity of red blood cells in storage and in circulation.

Another groundbreaking patent addresses the photoreactive inactivation of both extracellular and intracellular human pathogenic viruses in blood cell compositions. This method preserves the structural integrity of blood cells while effectively inactivating viruses, making it suitable for preparing transfusion-ready blood products. The process ensures that at least 77% of coagulation factors are retained, significantly benefiting patients in need of safe blood transfusions.

Career Highlights

Shanti B. Rywkin's career is marked by her tenure at the New York Blood Center, Inc., where she has contributed her expertise to advance blood safety technologies. Her research has played a crucial role in elevating the standards of blood product safety, thereby improving health outcomes for countless individuals.

Collaborations

Throughout her journey, Shanti has collaborated with esteemed colleagues, including Bernard Horowitz and Jay E. Valinsky. These collaborations have facilitated the sharing of ideas and resources, fostering an environment of innovation and advancement in the field of transfusion medicine.

Conclusion

Shanti B. Rywkin exemplifies the spirit of innovation in medical technology. Her patented processes not only contribute to the safety and quality of blood products but also reflect her commitment to enhancing patient care. As she continues her work at the New York Blood Center, her contributions will undoubtedly resonate within the medical community and beyond.